Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development

Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development

Background: mRNA-based cancer vaccines have been considered a promising anticancer therapeutic approach against various cancers, yet their efficacy for malignant mesothelioma (MESO) is still not clear. The present study is designed to identify MESO antigens that have the potential for mRNA vaccine d...

Full description

Bibliographic Details
Main Authors: Shuhang Wang, Yuqi Yang, Lu Li, Peiwen Ma, Yale Jiang, Minghui Ge, Yue Yu, Huiyao Huang, Yuan Fang, Ning Jiang, Huilei Miao, Hao Guo, Linlin Yan, Yong Ren, Lichao Sun, Yan Zha, Ning Li
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
tumor antigens
immune subtype
mRNA vaccine
malignant mesothelioma
tumor immune microenvironment
Online Access:https://www.mdpi.com/2076-393X/10/8/1168

Similar Items

Similar Items